Literature DB >> 35013932

Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion.

Yutaka Takagi1, Takashi Hatori2, Osamu Itano3, Masahiro Shinoda2, Atsushi Kato2, Nobuhiro Nitori2, Fumihiko Kato2, Ayu Kato2, Atsushi Nakao2, Takuya Tamura3, Shuichiro Uemura4, Masaru Miyazaki3, Shinsuke Aida5.   

Abstract

Pancreatic serous neoplasms are rare tumors that are usually benign. However, histopathological differentiation between benign (serous cystadenoma) and malignant (serous cystadenocarcinoma) lesions is difficult. We present the case of a patient with pancreatic serous cystadenocarcinoma that was diagnosed with liver metastasis 7 years after the resection of the primary serous neoplastic lesion. A woman in her 60 s was diagnosed with pancreatic serous cystadenoma based on imaging and histopathological examination findings. The tumor was resected, and the patient was followed up every 6 months to monitor tumor progression. At 7 years after the resection of the primary lesion, liver tumors showing marked flare-like contrast enhancements were detected on arterial phase computed tomography findings and on dynamic magnetic resonance imaging findings acquired 60 s after the administration of a contrast agent. Laparoscopic segmental hepatectomy of S4 and S6 was performed to resect these tumors. Histopathological examination revealed that these tumors were metastatic and developed from the primary lesion. Therefore, a diagnosis of serous cystadenocarcinoma was confirmed. The flare-like contrast enhancement around the metastatic liver lesions on computed tomography and dynamic magnetic resonance images may be an indicator of serous cystadenocarcinoma with liver metastasis that could assist in diagnosis.
© 2021. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Laparoscopic hepatectomy; Liver metastasis; Serous cystadenocarcinoma of the pancreas; Serous neoplasm of the pancreas

Mesh:

Year:  2022        PMID: 35013932     DOI: 10.1007/s12328-021-01570-9

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  2 in total

1.  Nonmucinous, glycogen-poor cystadenocarcinoma of the pancreas.

Authors:  H D Friedman
Journal:  Arch Pathol Lab Med       Date:  1990-08       Impact factor: 5.534

2.  Serous Microcystic Cystadenocarcinoma of the Pancreas with Synchronous Liver Metastases: Clinical Characteristics and Management.

Authors:  Dimitrios Massaras; Eirini V Pantiora; John Koutalas; Elias C Primetis; Georgios P Fragulidis
Journal:  Cureus       Date:  2020-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.